Obesity paradox in peripheral vascular disease

Atherosclerosis

Volumn 229, Issue 2, 2013, Pages 509-510

  Kato, Johji ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Mortality; Obesity; Peripheral vascular disease; Underweight

Indexed keywords

ADIPOCYTOKINE; ANGIOTENSINOGEN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ATHEROSCLEROSIS; BLOOD CLOTTING; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; KIDNEY FAILURE; MALNUTRITION; MESENTERIC ARTERY; MORTALITY; NOTE; NUTRITIONAL SUPPORT; OBESITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SECONDARY PREVENTION; SLEEP DISORDERED BREATHING; SUBCUTANEOUS FAT; UNDERWEIGHT;

MORTALITY; OBESITY; PERIPHERAL VASCULAR DISEASE; UNDERWEIGHT;

BODY MASS INDEX; FEMALE; HUMANS; MALE; OBESITY; PERIPHERAL VASCULAR DISEASES; THINNESS;

EID: 84880514355     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.05.004     Document Type: Note

References (15)

1. World Health Organization Obesity. Preventing and managing the global epidemic 2000, WHO, Geneva.
2. Hubert H.B., Feinleib M., McNamara P.M., Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983, 67:968-977.
3. Matsuzawa Y., Nakamura T., Shimomura I., Kotani K. Visceral fat accumulation and cardiovascular disease. Obes Res 1995, 3(Suppl. 5):645S-647S.
4. Nomura I., Kato J., Kitamura K. Association between body mass index and chronic kidney disease: a population-based, cross-sectional study of a Japanese community. Vasc Health Risk Manag 2009, 5:315-320.
5. Sciacqua A., Candigliota M., Ceravolo R., et al. Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care 2003, 26:1673-1678.
6. Fasshauer M., Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003, 46:1594-1603.
7. Moschen A.R., Molnar C., Geiger S., et al. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor α expression. Gut 2010, 59:1259-1264.
8. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., Heath C.W. Body-mass index andmortality in a prospective cohort of U.S. adults. NEngl J Med 1999, 341:1097-1105.
9. Oreopoulos A., Padwal R., Kalantar-Zadeh K., Fonarow G.C., Norris C.M., McAlister F.A. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156:13-22.
10. Romero-Corral A., Montori V.M., Somers V.K., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006, 368:666-678.
11. Ovbiagele B., Bath P.M., Cotton D., Vinisko R., Diener H.C. Obesity and recurrent vascular risk after a recent ischemic stroke. Stroke 2011, 42:3397-3402.
12. Jialin W., Yi Z., Weijie Y. Relationship between body mass index and mortality in hemodialysis patients: a meta-analysis. Nephron Clin Pract 2012, 121:c102-111.
13. Golledge J., Cronin O., Iyer V., Bradshaw B., Moxon J.V., Cunningham M. Body mass index is inversely associated with mortality in patients with peripheral vascular disease. Atherosclerosis 2013, 229(2):549-555.
14. Menotti A., Giampaoli S., Pasquali M., Seccareccia F., Stuart K. Prognosis of lean and fat hypertensives. Cardiology 1988, 75:448-457.
15. Stamler R., Ford C.E., Stamler J. Why do lean hypertensives have higher mortality rates than other hypertensives? findings of the hypertension detection and follow-up program. Hypertension 1991, 17:553-564.